Modern Diagnostic & Research Centre Limited, a comprehensive healthcare diagnostics services provider, is set to launch its Initial Public Offering (IPO) on December 31, 2025. The company aims to raise ₹29.69 crores through a fresh issue, with the offering closing on January 2, 2026.

Company Operations and Network

Founded in 2012, Modern Diagnostic & Research Centre Limited operates an extensive network of 21 centres across 8 states in India, comprising 18 laboratories and 3 diagnostic centres. The company provides integrated pathology and radiology testing services, including advanced imaging facilities such as 3Tesla MRI, 128 slice Dual Energy CT scans, and specialized genetic testing services.

Strong Financial Performance

The company has demonstrated remarkable financial turnaround over the past three years. Revenue from operations grew from ₹56.28 crores in FY2023 to ₹77.95 crores in FY2025, representing a compound annual growth rate of 17.80%. More significantly, the company transformed from a loss of ₹5.73 crores in FY2023 to a profit of ₹8.97 crores in FY2025.

IPO Fund Utilization Strategy

The proceeds from the IPO will be strategically deployed across multiple growth initiatives. The largest allocation of ₹20.69 crores (69.67%) will be invested in capital expenditure for medical equipment, including PET CT scanners and SPECT machines. Working capital requirements will receive ₹8.00 crores (26.94%), while ₹1.00 crore (3.37%) will be used for debt repayment.

Key Financial Ratios and Health

The company's financial health has shown consistent improvement across key metrics. Return on Equity improved dramatically from negative 96.14% in FY2023 to 45.46% in FY2025. The debt-to-equity ratio decreased from 5.13 to 2.27 over the same period, indicating better capital structure management.

Management and Strategic Advantages

The company is led by an experienced management team including Mr. Devendra Singh Yadav as Managing Director, Mrs. Deepali Yadav as Chief Executive Officer, and Mr. Ajay Kohli as Chief Operating Officer. The promoters and management team bring over 50 years of combined healthcare industry experience, providing strategic direction and operational expertise.

Modern Diagnostic & Research Centre Limited differentiates itself through comprehensive diagnostic services under one roof, offering cost-effective solutions with advanced technology. The company operates an advanced centralized IT platform that integrates its nationwide network through unified logistics and payment systems, enabling real-time tracking and providing healthcare providers secure online access to diagnostic results.

The healthcare diagnostics sector has witnessed increased investor interest, particularly following the pandemic's emphasis on diagnostic services. Modern Diagnostic & Research Centre Limited's established presence across multiple states, combined with its profitability and clear expansion strategy, positions it favorably in this growing market. The company's focus on high-end pathology services and advanced imaging capabilities addresses the increasing demand for sophisticated diagnostic solutions in India's evolving healthcare landscape.

Modern Diagnostic & Research Centre Limited, a comprehensive healthcare diagnostics services provider, has announced its ₹29.69 crore initial public offering scheduled to open on December 31, 2025. The company operates 21 centres including 18 laboratories and 3 diagnostic centres across 8 states, providing integrated pathology and radiology testing services.

IPO Structure and Timeline

The public offering comprises entirely of fresh issue shares worth ₹29.69 crore, with the bidding period running from December 31, 2025, to January 2, 2026. The company will utilize the proceeds primarily for capital expenditure on medical equipment and working capital requirements.

Fund Utilization Strategy

The net proceeds from the IPO will be allocated strategically across multiple growth initiatives. The largest portion of ₹20.69 crore will fund capital expenditure for advanced medical equipment including PET CT scanners and SPECT machines. Additionally, ₹8.00 crore will support working capital requirements, while ₹1.00 crore will be used for debt repayment.

Strong Financial Performance

Modern Diagnostic & Research Centre has demonstrated remarkable financial recovery and growth trajectory. The company achieved a significant turnaround from losses in FY23 to strong profitability, with revenue growing consistently over the past two years.

Business Operations and Technology

Founded in 2012 with a legacy dating back to 1985, the company provides comprehensive diagnostic services including advanced technologies like 3Tesla MRI, 128 slice Dual Energy CT scans, and genetic testing services. The company operates an advanced centralized IT platform that integrates its extensive network through unified logistics and payment systems.

Dr. Devendra Singh Yadav serves as Managing Director, leading a management team with over 50 years of combined healthcare industry experience. The company has established its reputation by delivering quality diagnostic services and processes samples from outside the country for high-end tests.

Investment Highlights

The IPO presents an opportunity to invest in India's growing healthcare diagnostics sector through a company showing strong operational metrics and consistent profitability improvement. Key strengths include comprehensive service offerings under one roof, experienced management team, and expanding network across multiple states with advanced medical equipment and technology infrastructure.